Throughout their lifetime, over 50% of women experience uUTIs, with recurrent infection reported in approximately 30%. Today, on March 25, 2025, the FDA approved a new first-in-class oral antibiotic for uncomplicated UTIs in women! This is Blujepa! In this episode, we will review the EAGLE clinical trial data and review the main side effects reported in the study population. How does this new antibiotic work? Will it be approved for pregnancy? And, what other genital condition could it likely be approved for? Listen in for details!

Podden och tillhörande omslagsbild på den här sidan tillhör Dr. Chapa’s Clinical Pearls. Innehållet i podden är skapat av Dr. Chapa’s Clinical Pearls och inte av, eller tillsammans med, Poddtoppen.

Dr. Chapa’s Clinical Pearls.

Introducing Blujepa!

00:00